MedTrace Logo

Trans-abdominal Fetal Pulse Oximetry: Signal Integrity

NCT04081623 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2021-08-11

No results posted yet for this study

Summary

This project is set up to advance and integrate the established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters,

Conditions

  • Fetal Distress

Interventions

DEVICE

Raydiant Oximetry Sensing System

The investigational device is used to record fetal pulse signals.

Sponsors & Collaborators

  • Raydiant Oximetry, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-16
Primary Completion
2021-05-20
Completion
2021-06-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04081623 on ClinicalTrials.gov